Trademark Overview
On Friday, October 29, 2021, a trademark application was filed for OBSIDIO GEM with the United States Patent and Trademark Office. The USPTO has given the OBSIDIO GEM trademark a serial number of 97099075. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, March 13, 2023. This trademark is owned by Obsidio, Inc.. The OBSIDIO GEM trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:
Pharmaceutical preparations for medical and surgical purposes in the nature of implantable materials, namely, hydrogels; pharmaceutical preparations for embolization therapy in interventional radiology and oncology in the nature of implantable materials, namely, hydrogels; medical preparations for embolization therapy in interventional radiology and oncology in the nature of implantable materials, namely, hydrogels; preparations for implantable surgical materials, namely, hydrogels; preparations for implantable hydrogel-based embolics; embolization therapy preparations; medical preparations for embolization therapy systems; medical preparations for vascular embolization, hemorrhage control, and peripheral hemostasis; surgical hydrogel precursors; surgical hydrogel precursors for kits for use in medical and surgical procedures comprised of precursors that react to form a hydrogel when combined with each other and applicators therefore; medical preparations used for embolization of vascu...
Surgical and medical apparatus and instruments for use in general surgery; medical apparatus and instruments for embolization; medical device, namely, arterial embolectomy device; medical device for embolization therapy in interventional radiology and oncology; embolic devices for interventional radiology, namely, interventional oncology and peripheral hemostasis; differentiated liquid embolics; medical device for vascular embolization procedures; medical device used for embolization of vascular lesions, tumors, targeted arterial segments of hypervascular tumors, control of bleeding due to disease or trauma, organs and segmental embolizations; medical devices, namely, syringes and delivery catheters for the delivery of embolic agents delivered through a microcatheter under fluoroscopic control; kits for use in medical and surgical procedures comprised of precursors that react to form a hydrogel when combined with each other and applicators therefore; medical apparatus, namely, system f...
